Sean Thomas Moriarty - 17 Feb 2026 Form 4 Insider Report for STEPAN CO (SCL)

Role
VP & GM Surfactants
Signature
/s/ James A. HArt, Attorney-in-Fact for Sean T. Moriarty
Issuer symbol
SCL
Transactions as of
17 Feb 2026
Net transactions value
+$19,718
Form type
4
Filing time
19 Feb 2026, 20:00:14 UTC
Previous filing
21 Mar 2025
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moriarty Sean Thomas VP & GM Surfactants 1101 SKOKIE BOULEVARD, SUITE 500, NORTHBROOK /s/ James A. HArt, Attorney-in-Fact for Sean T. Moriarty 19 Feb 2026 0001716333

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCL Common Stock Options Exercise $30,207 +455 +3.3% $66.39 14,303 17 Feb 2026 Direct F1
transaction SCL Common Stock Tax liability $10,490 -158 -1.1% $66.39 14,145 17 Feb 2026 Direct F2
holding SCL Common Stock 4,478 17 Feb 2026 By ESOP II Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCL Restricted Stock Units Options Exercise $0 -455 -100% $0.000000 0 17 Feb 2026 Restricted Stock Units 455 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award.
F2 Withholding of shares to satisfy tax liability on the vesting of RSUs.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
F4 Vests ratably over three years beginning on the date shown.